trial · primary record
Guselkumab
Crohns Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 196 |
| Primary completion | 2032-02-25 |
| Primary endpoint | Number of Participants with Treatment-Emergent Adverse Events as Assessment of Safety |
| Registry ID | NCT06663332 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:18.016Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06663332
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Guselkumab · approval
- Guselkumab · compound